ArticleGastroenterology2026

Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: 2026 Update.

Virginia Solitano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.